Ryoko Semba 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（13 件）

• [2026] Abstract PS5-02-19: Impact of HER2 kinase domain mutations on trastuzumab deruxtecan efficacy in HER2 low metastatic breast cancer
  DOI: https://doi.org/10.1158/1557-3265.sabcs25-ps5-02-19
• [2026] Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situ
  DOI: https://doi.org/10.1016/j.humpath.2026.106172
• [2026] Radiation-Induced Angiosarcoma Following Breast Surgery: A Case Report
  DOI: https://doi.org/10.70352/scrj.cr.25-0674
• [2026] Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing
  DOI: https://doi.org/10.1007/s12282-026-01868-x
• [2025] Assessing the Reliability and Validity of Principles for Health-Related Information on Social Media (PRHISM) for Evaluating Breast Cancer Treatment Videos on YouTube: Instrument Validation Study
  DOI: https://doi.org/10.2196/66416
• [2025] Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility
  DOI: https://doi.org/10.1007/s12282-025-01796-2
• [2025] Two-hit events occurred independently in bilateral breast cancers in a germline double heterozygous carrier for BRCA1 and BRCA2
  DOI: https://doi.org/10.1007/s12282-025-01740-4
• [2025] A Case Report of Severe Thrombocytopenic Purpura during Neoadjuvant Pembrolizumab Administration for Triple-Negative Breast Cancer
  DOI: https://doi.org/10.70352/scrj.cr.24-0036
• [2024] Attempt to Substitute the Oncotype DX Breast Recurrence Score® Test by Histopathological Factors and MUC1 Protein Expression
  DOI: https://doi.org/10.21873/cdp.10349
• [2024] A case of phyllodes tumor with rapid growth during pregnancy and lactation period: a case report
  DOI: https://doi.org/10.1186/s40792-024-01895-w

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。